Turner Christopher Durant 4
4 · Nuvalent, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Turner Christopher Durant
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-05+47,500→ 47,500 totalExercise: $72.35Exp: 2034-01-05→ Class A Common Stock (47,500 underlying) - Award
Class A Common Stock
2024-01-05+33,300→ 47,813 total
Footnotes (2)
- [F1]Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following January 5, 2024, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- [F2]The shares underlying this option vest over the next four years in equal monthly installments following January 5, 2024, subject to continued service to Nuvalent, Inc. through the applicable vesting date.